← Evidence map

ReviewAdvances in therapy2022

The Antifibrotic Effects of Inhaled Treprostinil: An Emerging Option for ILD.

Martin Kolb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

25 papers cite it

2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 35781186